Japanese English 中文

Sponsored Links

Ophthalmology Clinic Succession Guide: Key Points for M&A and Business Succession

📖 Approx. 7 min read

M&A and business succession for ophthalmology clinics are highly specialized fields, making it essential to understand their unique considerations. Specifically, there are numerous points to examine, such as evaluating revenue streams like cataract surgery equipment and contact lens sales, handling assets unique to medical corporations (membership interests, funds, etc.), and ensuring alignment with regional healthcare plans. This article explains the key points that specialists in medical M&A and business succession should focus on to achieve a smooth succession for ophthalmology clinics, incorporating specific visual elements.

Types of Medical Corporations and Their Impact on Succession

Medical corporations are broadly categorized into two main types: “membership interest corporations” and “non-membership interest corporations (corporate medical organizations).” The corporate structure significantly influences the M&A scheme and taxation during succession. In membership interest corporations, succession typically proceeds through the transfer or inheritance of membership interests (equity interests) of directors or members. However, the valuation of these interests and their tax treatment (capital gains tax, inheritance/gift tax) are complex. In contrast, non-membership interest corporations do not have membership interests; succession occurs through the election of directors by the general meeting of members or changes in officers. In such cases, schemes like the dissolution and establishment of a new medical corporation or business transfer may be considered. Regardless of the type, careful consideration must be given to how assets of the medical corporation are transferred, particularly medical service fees receivable, fixed assets (surgical equipment, buildings, etc.), and carried-forward losses. For fund-contributing medical corporations, it is also necessary to confirm the regulations regarding the refund and transfer of funds. In relation to regional healthcare plans, the continuation or expansion of medical services and the continuity of the organization’s role in the community after succession may differ depending on the type of medical corporation.

Asset Valuation Specific to Ophthalmology Clinics: Surgical Equipment and Contact Lens Sales

In the M&A of ophthalmology clinics, profitability assessment is extremely important. In particular, the valuation of high-value surgical equipment used for cataract surgery (e.g., femtosecond lasers, ultrasonic phacoemulsification systems) is carefully conducted, considering factors such as remaining useful life, maintenance contract status, and the replacement cycle for newer models. These devices are assets that significantly impact the clinic’s profitability, and considerations include off-balance-sheet asset valuation and the transfer of lease agreements. Furthermore, contact lens sales are a stable source of revenue for ophthalmology clinics. When evaluating these sales, it is necessary to consider not only sales performance but also procurement channels, inventory management, customer loyalty, and the competitive landscape. During M&A due diligence (DD), a detailed analysis is required to determine if these assets are appropriately valued and how they will affect future revenue projections. The selling party must accurately assess the value of these assets and prepare for appropriate price negotiations.

Asset Item Valuation Points Considerations at Succession
Cataract Surgery Equipment Remaining useful life, maintenance contract, comparison with new models, used market price Transfer of depreciation expenses, presence of lease agreements, transfer of maintenance contracts
Contact Lens Inventory/Sales Sales performance, procurement costs, customer data, competitor trends Inventory valuation, transfer of supplier contracts, maintenance/expansion of sales channels
Medical Service Fees Receivable Collectability, presence of aged receivables Reflection in transfer price, transfer of collection process
Buildings and Facilities Age, repair history, location, lease agreement Confirmation of rent, contract period, obligation for restoration to original condition
Key Asset Valuation and Succession Considerations for Ophthalmology Clinics (Indicative)

Impact of Licenses, Notifications, and Medical Fee Revisions

Operating a medical institution requires indispensable licenses and various notifications from public health centers and other authorities. For ophthalmology clinics, these include facility permits, designation as an insured medical institution, and designation as a medical institution handling specific disease treatment vouchers. During M&A or business succession, it is crucial to confirm whether these licenses will be validly transferred or if reapplication is necessary. In particular, depending on the scheme, such as a change in corporate status or business transfer, reacquisition of licenses may be required. Furthermore, since medical fees are the foundation of a medical institution’s revenue, trends in medical fee revisions significantly impact succession planning. Recent revisions have promoted online eligibility verification, strengthened primary care physician functions, and improved the evaluation of advanced medical technologies. When considering succession, it is essential to develop a business plan that takes into account recent revision details and the risks of future medical fee fluctuations. Specific strategies must be devised on how the clinic will secure revenue within the new medical fee system after succession.

Business Succession Steps and Utilization of Experts

The business succession of an ophthalmology clinic generally proceeds in the following steps. First, clarify the objectives of succession and desired conditions (e.g., desired transfer price, succession timing) and consult with experts (M&A intermediaries, tax accountants, lawyers, etc.). Next, search for potential medical institutions and conduct initial information exchange. If both parties confirm their intention to proceed after information exchange, a Non-Disclosure Agreement (NDA) is signed, leading to detailed information disclosure (due diligence). Due diligence involves a thorough investigation of financial, legal, and operational aspects of the medical institution. Based on the findings of this investigation, final transfer terms are negotiated, leading to the signing of a Memorandum of Understanding (MOU). Subsequently, a definitive agreement (M&A agreement, business transfer agreement, etc.) is executed, followed by procedures for license transfer and payment settlement, completing the succession. This entire process requires specialized knowledge and experience, and expert support, particularly regarding issues unique to medical institutions and medical M&A, is key to success.

  1. Clarification of Objectives/Conditions and Consultation with Experts: Organize succession objectives and desired conditions (transfer price, timing, terms, etc.) and consult with experts such as M&A advisors, tax accountants, and lawyers.
  2. Search for Candidate Medical Institutions and Initial Information Exchange: Search for successors/transferors that match the desired conditions. Begin anonymous information exchange.
  3. Execution of Non-Disclosure Agreement (NDA): Sign an NDA to build mutual trust and prevent information leakage.
  4. Conduct Due Diligence (DD): Perform detailed investigations including financial, legal, and operational aspects of the medical institution.
  5. Negotiation of Terms and Signing of Memorandum of Understanding (MOU): Negotiate the transfer price, contract terms, etc., based on DD findings, and sign an MOU.
  6. Execution of Definitive Agreement (M&A Agreement, etc.): Prepare and execute a detailed definitive agreement based on the MOU.
  7. License Transfer, Payment Settlement, and Succession Completion: Apply for and transfer licenses to relevant authorities, settle the purchase price, and complete the succession.

Considerations for Funds, Member Changes, and Taxation in Medical Corporations

The handling of funds in medical corporations is a significant issue in succession. Funds are capital contributed by directors or members for the establishment and operation of the medical corporation and may be distinguished from the corporation’s assets. Confirmation of the refund of funds and their attribution to the medical corporation after succession is necessary based on the articles of incorporation and board meeting minutes. Generally, funds are to be refunded upon the dissolution of the corporation or when events stipulated in the articles of incorporation occur. However, depending on the M&A scheme, the successor may assume the obligation to refund the funds, or the amount equivalent to the refund may be settled as part of the transfer price. Furthermore, changes in members (shareholders) are a primary procedural aspect of succession, especially for membership interest corporations. Changes in membership require company registration and procedures for the transfer of membership interests. It is essential to confirm the tax implications (capital gains tax, gift tax, etc.) associated with these changes in advance. Capital gains tax is levied on the amount obtained by subtracting acquisition costs and transfer expenses from the transfer price. However, the valuation of membership interests in a medical corporation requires specialized knowledge, so consultation with experts such as tax accountants is recommended.

Sponsored Links

✅ Key Points for Succession Preparation

  • Confirmation of corporate structure (membership interest type / non-membership interest type)
  • Grasping the existence and valuation of membership interests and funds
  • Confirmation of the status and transferability of licenses and notifications
  • Impact of medical fee revisions and outlook for future revenue
  • Asset valuation of surgical equipment, contact lens sales, etc.
  • Confirmation of the clinic’s role within the regional healthcare plan

Regional Healthcare Plans and Post-Succession Vision

Regional healthcare plans are national policies aimed at differentiating and coordinating hospital bed functions and enhancing home medical care and long-term care. They are an element that cannot be ignored in the succession of medical institutions. It is important to consider what role the ophthalmology clinic plays within the regional healthcare plan and whether this role can be continued and developed after succession. For example, this could include ensuring access to advanced ophthalmological surgery in the region, strengthening collaboration with secondary care hospitals, and establishing a system for information sharing with primary care physicians. When considering succession, it is desirable for the acquiring party to align their business strategy with the regional healthcare plan, and for the transferring party to choose a successor who will continue the clinic’s contribution to the region. Since medical fee revisions also have aspects that align with the promotion of regional healthcare plans, it is crucial to monitor trends in both. Clarifying the post-succession vision and continuing contributions to regional healthcare are essential for fulfilling the mission of a medical institution and achieving sustainable management.

M&A and business succession for ophthalmology clinics are complex processes requiring specialized knowledge and careful planning. At M&A Medical, our specialists in medical corporation M&A and business succession provide comprehensive support, from proposing the optimal succession scheme tailored to your clinic’s situation to conducting due diligence, negotiating contracts, and handling license procedures. Please begin by sharing your clinic’s current status and your aspirations. We offer free consultations to provide concrete advice for achieving a smooth succession for your clinic.


Consult M&A Medical for Medical Succession

M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the successful transfer of clinics and medical corporations facing succession issues, as well as strategic acquisitions, on a success fee basis.

  • Initial consultation and preliminary appraisal are free
  • No retainer or monthly fees (success fee only)
  • Strict confidentiality (proceeding after signing NDA)
  • Service available nationwide (all 47 prefectures) and for all medical specialties

Please consult us early in your consideration phase, whether you simply want to understand market value, have no successor, or are considering joining a group.

Apply for Free Consultation

Related Sponsors

— End of Column —

📧 NEWSLETTER

Medical M&A and Business Succession NewsEvery MondayDelivered (Free, 1 item via email)

Consult for FreeStrictly Confidential, Submit in 1 Minute
Protected by reCAPTCHA · Privacy · Terms